Empowered Funds LLC Makes New $3.01 Million Investment in Doximity, Inc. (NASDAQ:DOCS)

Empowered Funds LLC bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 56,357 shares of the company's stock, valued at approximately $3,009,000.

A number of other institutional investors have also recently bought and sold shares of DOCS. UMB Bank n.a. boosted its position in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Farther Finance Advisors LLC lifted its position in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after acquiring an additional 603 shares in the last quarter. Morse Asset Management Inc bought a new stake in Doximity in the 3rd quarter valued at $46,000. Covestor Ltd lifted its position in Doximity by 441.9% during the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company's stock worth $73,000 after buying an additional 1,370 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock worth $93,000 after buying an additional 296 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 37.40% of the company's stock.

Doximity Stock Up 0.2 %

NASDAQ DOCS traded up $0.14 on Monday, hitting $77.13. The company's stock had a trading volume of 2,886,369 shares, compared to its average volume of 1,531,451. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21. The company's 50-day moving average is $58.36 and its 200 day moving average is $47.99. The firm has a market cap of $14.40 billion, a PE ratio of 77.13, a PEG ratio of 4.61 and a beta of 1.39.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Stephens began coverage on shares of Doximity in a research report on Friday, December 20th. They set an "equal weight" rating and a $55.00 price target on the stock. Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and upped their price target for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Truist Financial upped their price target on shares of Doximity from $35.00 to $49.00 and gave the company a "hold" rating in a research note on Thursday, November 14th. The Goldman Sachs Group increased their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Finally, Canaccord Genuity Group lowered shares of Doximity from a "buy" rating to a "hold" rating and increased their target price for the stock from $40.00 to $60.00 in a research report on Wednesday, November 13th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.